GlassScriptPhysician profile
Albert I Richardson
NPI 1558469981
$102,595.63
in general payments reported to CMS, 2019-2025
28 companies · $31K in 2025
The $31K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $611 · 2021: $468 · 2022: $1,131 · 2023: $32K · 2024: $37K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $98K · Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $97,833.33 |
| Food and Beverage | $2,071.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $98,262.26 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $1,897.17 | 2019-2025 | General - Vascular Intervention, Ranger, Eluvia |
| Medtronic, INC. | $410.92 | 2021-2024 | Endurant Iis |
| Endologix LLC | $357.43 | 2022 | |
| Organogenesis INC. | $352.36 | 2022-2025 | Puraply, Affinity |
| Penumbra, INC. | $199.05 | 2024-2025 | Indigo System |
| Medtronic Vascular, INC. | $198.60 | 2020 | |
| W. L. Gore & Associates, INC. | $186.08 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Silk Road Medical, INC. | $94.54 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Pfizer INC. | $81.75 | 2019-2021 | |
| Philips North America LLC | $68.81 | 2021 | |
| Bard Peripheral Vascular, INC. | $67.75 | 2019-2021 | |
| Lemaitre Vascular, INC. | $62.03 | 2022-2024 | Artegraft Vascular Graft, Syntel Embolectomy Catheter (Spring Tip) |
| Shockwave Medical, INC | $57.81 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Venclose INC. | $41.98 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $30.53 | 2022-2024 | Collagenase Santyl |
| Cardiovascular Systems INC. | $29.29 | 2019-2021 | |
| Merz North America, INC. | $27.92 | 2025 | |
| Mimedx Group, INC. | $26.54 | 2024 | |
| Tactile Systems Technology INC | $22.74 | 2019 | |
| Solventum Corporation | $20.78 | 2025 | Prevena |
| Cook Medical LLC | $16.05 | 2022 | |
| Kci USA, INC. | $16.05 | 2021 | |
| Cardiva Medical, INC. | $13.91 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.91 | 2021 | |
| Stryker Corporation | $13.87 | 2025 | Artix Mt |
| Janssen Pharmaceuticals, INC | $13.37 | 2021 | |
| Veryan Medical Incorporated | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.